List of Studies ( Metabolite:TG 57:5)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Analysis Type |
|---|---|---|---|---|---|---|---|
| ST004095 | AN006788 | Hep3B PNPLA3 wild type and PNPLA3(I148M) lipidomics | Cultured cells | Human | Cancer | Amgen | LC-MS |
| ST003776 | AN006202 | Investigation of Hepatic Lipid Alterations Following Micro- and Nanoplastic-Ingestion | Liver | Mouse | Environmental exposure | University of Bonn | LC-MS |
| ST003702 | AN006074 | Kupffer cells control neonatal hepatic glucose metabolism via Igf1 signaling - lipidomics analysis of postnatal day 0 murine livers after macropahges depletion using Csf1r conditional KO | Liver | Mouse | University of Bonn | LC-MS | |
| ST003614 | AN005939 | Kupffer cells control neonatal hepatic glucose metabolism via Igf1 signaling - lipidomics analysis of postnatal day 0 murine livers after macropahges depletion | Liver | Mouse | University of Bonn | LC-MS | |
| ST003456 | AN005677 | Lipidomics of human serum to support understanding of early metabolic shift in presymptomatic sepsis patients. (Part2 human lipids) | Blood | Human | Sepsis | Leibniz Institute for Natural Product Research and Infection Biology Hans Knöll Institute | LC-MS |
| ST003220 | AN005280 | Obesity, sex, and depot drive distinct lipid profiles in murine white adipose tissue | Adipose tissue | Mouse | Obesity | University of Utah | LC-MS |
| ST001950 | AN003174 | Lipidome Alterations Following Mild Traumatic Brain Injury. | Blood | Rat | Traumatic brain injury | Georgia Institute of Technology | LC-MS |
| ST001292 | AN002149 | Metabolomics of blood plasma and kidney tissue from control (db/m) and diabetic (db/db) mice. | Kidney | Mouse | Diabetes | University of Michigan | LC-MS |
| ST001067 | AN001746 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001067 | AN001746 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Brain | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001067 | AN001746 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Liver | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001067 | AN001746 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Muscle | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001066 | AN001744 | Lipidomics analysis for aged mice liver (part-III) | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001066 | AN001744 | Lipidomics analysis for aged mice liver (part-III) | Brain | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001066 | AN001744 | Lipidomics analysis for aged mice liver (part-III) | Liver | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001066 | AN001744 | Lipidomics analysis for aged mice liver (part-III) | Muscle | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001063 | AN001739 | Lipidomics analysis for aged mice organs | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001063 | AN001739 | Lipidomics analysis for aged mice organs | Brain | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001063 | AN001739 | Lipidomics analysis for aged mice organs | Liver | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001063 | AN001739 | Lipidomics analysis for aged mice organs | Muscle | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST000917 | AN001500 | Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 3:Urine | Urine | Human | Fatty liver disease | LIPID MAPS | GC-MS/LC-MS |
| ST000916 | AN001494 | Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 2:Plasma | Blood | Human | Fatty liver disease | LIPID MAPS | GC-MS/LC-MS |
| ST000915 | AN001488 | Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 2:Liver | Liver | Human | Fatty liver disease | LIPID MAPS | GC-MS/LC-MS |
| ST000688 | AN001062 | Biomarkers for different types of Multiple Scelerosis (MS) (BMS vs SPMS lipidomics) | Unspecified | Human | Multiple sclerosis | University of Michigan | LC-MS |
| ST000675 | AN001037 | Effects of rosiglitazone treatment on lipid composition | Adipose tissue | Human | University of Michigan | LC-MS | |
| ST000666 | AN001019 | Rat Rotator Cuff Lipidomics | Muscle | Rat | University of Michigan | LC-MS | |
| ST000665 | AN001017 | Nonalcoholic fatty liver disease (NAFLD) Studies | Cultured cells | Human | Fatty liver disease | University of Michigan | LC-MS |
| ST000662 | AN001011 | Lipidomics of hormone-sensitive lipase variants | Adipose tissue | Human | University of Michigan | LC-MS | |
| ST000661 | AN001009 | CHOICE clinical weight loss study | Blood | Human | Obesity | University of Michigan | LC-MS |
| ST000661 | AN001009 | CHOICE clinical weight loss study | Blood | Rat | Obesity | University of Michigan | LC-MS |
| ST000114 | AN000192 | SIRM Analysis of human P493 cells under hypoxia in [U-13C] labeled Glucose medium | B-cells | Human | Cancer | University of Kentucky | GC-MS/LC-MS |
| ST000113 | AN000190 | SIRM Analysis of human P493 cells under hypoxia in [U-13C/15N] labeled Glutamine medium (Positive ion mode FTMS) | B-cells | Human | Cancer | University of Kentucky | GC-MS/LC-MS |
| ST000005 | AN000012 | Timecourse on RAW 264.7 cells treated with Kdo2-Lipid A and compactin | Macrophages | Mouse | LIPID MAPS | GC-MS/LC-MS |
